NEW YORK ( TheStreet) -- CHANGE IN RATINGSCephalon ( CEPH) downgraded at BofA/Merrill to Neutral from Buy on valuation. Maintain $75 price target. 2010 and 2011 EPS estimates held at $6.52 and $6.70, respectively. Cephalon ( CEPH) target raised at UBS to $80. Company is seeing better prescription trends. Buy rating. DuPont Fabros Technology ( DFT) initiated at Barclays with an Overweight rating and $25 price target. 2010 and 2011 EPS estimates set at $1.24 and $1.60, respectively. Digital River ( DRIV) upgraded at FBR from Market Perform to Outperform. Company is likely seeing an improved business pipeline. $36 price target. Fresh Del Monte ( FDP) downgraded at Suntrust from Buy to Neutral. See few meaningful catalysts on the horizon. Public Service Enterprise ( PEG) rated new Neutral at Goldman. $34 price target. Earnings growth in the regulated business will likely be offset by lower merchant generation results. Psychiatric Solutions ( PSYS) downgraded at Piper Jaffray. Rating lowered to Underweight from Neutral. Price target raised to $30 from $24. Maintains 2010 EPS estimates of $2.30. SAIC ( SAI) downgraded at Wells to Market Perform. Company lowered guidance as it's seeing award delays. Wellpoint ( WLP) upgraded at BMO from Market Perform to Outperform. $75 price target.
Intercontinental Exchange ( ICE) numbers upped at Morgan Stanley. Shares of ICE now seen reaching $118. Estimates also raised, as the company should benefit from higher OTC and energy volumes. Equal-weight rating. Linear Technology ( LTC) estimates upped at FBR. LLTC estimates were raised through 2011. Checks suggest that quarterly sales are tracking at the high end of expectations. Underperform rating and $31 price target. McDermott International ( MDR) price target higher at Barclays. MDR price target jumped to $33 from $29 on improving prospects. 2010 and 2011 EPS estimates held at $1.85 and $2.15, respectively. Maxim Integrated ( MXIM) numbers raised at FBR. Shares of MXIM now seen reaching $23. Estimates also increased, following robust channel checks. Market Perform rating. NYSE Euronext ( NYX) estimates lowered at Morgan Stanley through 2011. Company likely seeing lower volumes and losing market share. Equal-weight rating and $31 price target. Target ( TGT) numbers boosted at Goldman. Shares of TGT now seen reaching $53. Estimates also upped, given improving credit trends. Neutral rating.